WO2011050107A3 - Compositions and methods for delivery of therapeutic agents to the cns - Google Patents
Compositions and methods for delivery of therapeutic agents to the cns Download PDFInfo
- Publication number
- WO2011050107A3 WO2011050107A3 PCT/US2010/053439 US2010053439W WO2011050107A3 WO 2011050107 A3 WO2011050107 A3 WO 2011050107A3 US 2010053439 W US2010053439 W US 2010053439W WO 2011050107 A3 WO2011050107 A3 WO 2011050107A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cns
- therapeutic agents
- delivery
- compositions
- human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
Abstract
The present invention provides compositions and methods for sustained delivery of therapeutic agents to the CNS, using a novel implant material composed of fibrillar collagen coated with human laminin, allowing increased implant biocompatibility to sustain more efficient delivery of therapeutic agents to the CNS, which is an improvement in the field of sustained delivery of therapeutic agents to the CNS. This composition can be implanted in the CNS where needed and will persist for long times with minimal tissue reaction. The compositions are fibrillar collagen porous matrices coated with human laminin, to treat resection cavities of CNS tumors, which can be used to provide a sustained release delivery vehicle for therapeutic agents including chemotherapeutic drugs or tumor-targeting human cells from cultures, such as human neural progenitor cells.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25311109P | 2009-10-20 | 2009-10-20 | |
US61/253,111 | 2009-10-20 | ||
US30640510P | 2010-02-19 | 2010-02-19 | |
US61/306,405 | 2010-02-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011050107A2 WO2011050107A2 (en) | 2011-04-28 |
WO2011050107A3 true WO2011050107A3 (en) | 2012-05-10 |
Family
ID=43900948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/053439 WO2011050107A2 (en) | 2009-10-20 | 2010-10-20 | Compositions and methods for delivery of therapeutic agents to the cns |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011050107A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3226798A1 (en) * | 2014-12-01 | 2017-10-11 | Brainlab AG | Method for determining the structure of a medical implant for replacing removed tissue |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020082698A1 (en) * | 2000-09-18 | 2002-06-27 | Parenteau Nancy L. | Method for treating a patient using a cultured connective tissue construct |
US20090069903A1 (en) * | 2007-07-03 | 2009-03-12 | Histogenics Corporation | Method For Improvement Of Differentiation Of Mesenchymal Stem Cells Using A Double-Structured Tissue Implant |
US20090142409A1 (en) * | 2007-05-10 | 2009-06-04 | Firestone Leigh H | Extracellular Matrix Compositions for Tissue Regeneration |
-
2010
- 2010-10-20 WO PCT/US2010/053439 patent/WO2011050107A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020082698A1 (en) * | 2000-09-18 | 2002-06-27 | Parenteau Nancy L. | Method for treating a patient using a cultured connective tissue construct |
US20090142409A1 (en) * | 2007-05-10 | 2009-06-04 | Firestone Leigh H | Extracellular Matrix Compositions for Tissue Regeneration |
US20090069903A1 (en) * | 2007-07-03 | 2009-03-12 | Histogenics Corporation | Method For Improvement Of Differentiation Of Mesenchymal Stem Cells Using A Double-Structured Tissue Implant |
Also Published As
Publication number | Publication date |
---|---|
WO2011050107A2 (en) | 2011-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Deng et al. | Repair of critical-sized bone defects with anti-miR-31-expressing bone marrow stromal stem cells and poly (glycerol sebacate) scaffolds | |
Crupi et al. | Inflammation in tissue engineering: The Janus between engraftment and rejection | |
Gao et al. | Polydopamine-templated hydroxyapatite reinforced polycaprolactone composite nanofibers with enhanced cytocompatibility and osteogenesis for bone tissue engineering | |
Tierney et al. | The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds | |
Wu et al. | MicroRNA functionalized microporous titanium oxide surface by lyophilization with enhanced osteogenic activity | |
WO2009102452A3 (en) | Compositions and methods for implantation of adipose tissue and adipose tissue products | |
Kuo et al. | Chitosan/γ-poly (glutamic acid) scaffolds with surface-modified albumin, elastin and poly-L-lysine for cartilage tissue engineering | |
WO2009100280A3 (en) | 3-dimensional silk hydroxyapatite compositions | |
Deng et al. | Bioceramic scaffolds with antioxidative functions for ROS scavenging and osteochondral regeneration | |
WO2006081435A3 (en) | Method of providing readily available cellular material derived from cord blood, and a composition thereof | |
WO2006084209A3 (en) | Rnai expression constructs | |
TW200633733A (en) | Biomaterials for guided tissue regeneration and drug delivery | |
WO2008054466A3 (en) | Delivery of biologically active materials using core-shell tecto (dendritic polymers) | |
NZ603913A (en) | Method of engrafting cells from solid tissues | |
WO2004047747A3 (en) | Compositions and methods for cell dedifferentiation and tissue regeneration | |
NZ591146A (en) | Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills | |
EP2309989A4 (en) | Drug loaded polymeric nanoparticles and methods of making and using same | |
WO2009134866A3 (en) | Cell membrane engineering | |
WO2003099225A3 (en) | Compositions for delivering nucleic acids to cells | |
MY158100A (en) | 6,9-disubstituted purine derivatives and their use for treating skin | |
ATE445417T1 (en) | EX VIVO METHODS AND COMPOSITIONS FOR NUCLEIC ACID ADMINISTRATION | |
EP2029754A4 (en) | Magnetosome gene expression in eukaryotic cells | |
Aframian et al. | Current status of the development of an artificial salivary gland | |
WO2010082787A2 (en) | Pharmaceutical composition for bone-disease treatment or countering inflammation, comprising cartilage stem cells as an active principle | |
MX2021003552A (en) | Implantable devices for cell therapy and related methods. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10825630 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A DATED 18.09.2012 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10825630 Country of ref document: EP Kind code of ref document: A2 |